December 20, 2023

• Major pharmaceuticals issues a voluntary class I recall of phenytoin oral suspension

December 18, 2023

• InvaGen Pharmaceuticals issues a voluntary consumer level recall of vigabatrin for oral solution

December 14, 2023

• Sun Pharmaceuticals issues a voluntary class II recall of liothyronine tablets

December 13, 2023

• Lupin Pharmaceuticals issues voluntary class II recall of penicillamine tablets

December 7, 2023

• Baxter Healthcare issues voluntary class II recall of ondansetron injection

December 5, 2023

• Padagis issues a voluntary class II recall of trospium extended release capsules

November 27, 2023

• Glenmark pharmaceuticals issues voluntary class II recall of naproxen tablets
• Novartis issues voluntary consumer level recall of Sanimmune oral solution
• Apotex issues voluntary class II recall of paroxetine
• Apotex issues voluntary class II recall of paroxetine
• Apotex issues voluntary class II recall of paroxetine
• Apotex issues voluntary class II recall of paroxetine

November 21, 2023

• ITF Pharma issues a voluntary class II recall of Tiglutil suspension

November 17, 2023

• Bayer issues a voluntary consumer level recall of Vitrakvi

November 8, 2023

• Glenmark Pharmaceuticals issues a voluntary class II recall of deferasirox tablets
• Zydus issues a voluntary class II recall of oxybutynin extended-release tablets
• Zydus issues a voluntary class II recall of oxybutynin extended-release tablets
• Zydus issues a voluntary class II recall of oxybutynin extended-release tablets

November 7, 2023

• Glenmark Pharmaceuticals issues a voluntary class II recall of ranolazine tablets
• Medline issues a voluntary class II recall of miconazole nitrate antifungal

November 3, 2023

• Dr. Reddy’s Laboratories, Inc. issues a voluntary class II recall of montelukast tablets

November 1, 2023

• Harvard Drug Group. LLC issues voluntary consumer-level recall of ophthalmic products

October 27, 2023

• GlaxoSmithKline LLC issues a voluntary class II recall of TUMS antacids

October 26, 2023

• Exela Pharma Sciences, LLC issues a voluntary consumer level recall of sodium bicarbonate injection, midazolam injection, and ELCYS injection

October 17, 2023

• Baxter Healthcare Corporation issues a voluntary class II recall of doxil single dose vial

October 16, 2023

• VistaPharm LLC issues a voluntary class I recall of sucralfate oral suspension

October 3, 2023

• Oncology Drug Exkivity to be Withdrawn from U.S. Market
• KVK-Tech, Inc. issues voluntary consumer level recall of Betaxolol tablets

October 2, 2023

• Hospira, Inc. issues a voluntary user level recall of sodium bicarbonate injection and lidocaine injection

September 28, 2023

• Scynexis, Inc. issues a voluntary consumer level recall of Brexafemme tablets

September 27, 2023

• Delpharm issues a voluntary class I recall of Sandimmune oral solution

September 18, 2023

• Marlex Pharmaceuticals issues a voluntary class II recall of digoxin 0.25 mg tablets
• Marlex Pharmaceuticals issues a voluntary class I recall of digoxin 0.125 mg tablets

September 11, 2023

• Novartis issues a voluntary consumer level recall of Sandimunne oral solution
• VistaPharm LLC issues a voluntary class II recall of sucralfate oral suspension

September 6, 2023

• Lunback issues a voluntary class III recall of Sabril for oral solution
• Contract Pharmaceuticals issues a voluntary class III recall of clindamycin topical solution

August 29, 2023

• Baxter Healthcare issues a voluntary class II recall of Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose
• Baxter Healthcare issues a voluntary class II recall of Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose

August 24, 2023

• Ecometics, Inc. issues voluntary class II recall of AstrinGyn vials
• Ecometics, Inc. issues voluntary class II recall of Lugol’s solution

August 18, 2023

• Aurobindo Pharma issues a voluntary class II recall of rufinamide tablets

July 31, 2023

• Ritedose Corporation issues voluntary class II recall of cromolyn oral solution

July 24, 2023

• Sun Pharmaceuticals issues a voluntary class II recall of methylphenidate 20 mg tablets

July 21, 2023

• Glenmark Therapeutics voluntary class II recall of famotidine 20 mg tablets

July 19, 2023

• SterRx, LLC issues voluntary class II recall of Sodium Bicarbonate in 5% Dextrose Injection
• SterRx, LLC issues voluntary class II recall of Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride
• SterRx, LLC issues voluntary class II recall of Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride
• SterRx, LLC issues voluntary class II recall of Norepinephrine 16 mg per 250 mL (64 mcg per mL) in 0.9% Sodium Chloride
• SterRx, LLC issues voluntary class II recall of Norepinephrine 32 mg per 250 mL (128 mcg per mL) in 0.9% Sodium Chloride

July 18, 2023

• scend Laboratories issues a voluntary class II recall of fingolimod capsules 0.5 mg

July 13, 2023

• B.Braun Medical Inc. Issues a voluntary class II recall of 0.9% Sodium Chloride Injection Excel Plus Container

July 7, 2023

• Cipla issues voluntary consumer level recall of albuterol inhalation aerosol

July 6, 2023

• Vivimed Life Sciences issues voluntary class II recall of losartan tablets

July 5, 2023

• Preferred Pharmaceuticals, Inc. issues voluntary class II recall of tizanidine tablets

June 26, 2023

• Sun Pharmaceuticals issues voluntary class II recall of tramadol tablets
• Homeocare Laboratories issues voluntary class II recall of StellaLife Peppermint Dental Rinse and Dental Gel
• Homeocare Laboratories issues voluntary class II recall of StellaLife Peppermint Dental Rinse and Dental Gel

June 23, 2023

• Lupin issues a voluntary consumer level recall of Tydemy tablets

June 15, 2023

• Amneal Pharmaceuticals issues a voluntary class II recall of phenytoin capsules

June 14, 2023

• The Harvard Drug Group, LLC issues a consumer level voluntary recall of dronabinol capsules and ziprasidone capsules

June 7, 2023

• Sun Pharmaceuticals issues a voluntary class II recall of buprenorphine sublingual 8 mg tablets

June 6, 2023

• Novis issues a voluntary class I recall of over-the-counter G-Supress DX Pediatric Drops

June 5, 2023

• Viatris Company issues a voluntary class II recall of Levsin injection
• Empower Pharmacy issues a voluntary class II recall of ascorbic acid preserved injection solution

May 25, 2023

• Revive Rx Pharmacy voluntary class II recall of Tirzepatide 10 mg/0.5 mL Sterile Solution

May 23, 2023

• Sun pharmaceuticals voluntary recall of bupropion ER tablets

May 19, 2023

• BluePoint Labs voluntary recall of glimepiride tablets

May 16, 2023

• Remedy Repack voluntary recall of lorazepam injection
• Remedy Repack voluntary recall of ketotifen antihistamine eye drops

May 15, 2023

• NOVIS PR LLC voluntary recall of G-Supress DX Pediatric Drops,
• Hikma Pharmaceuticals voluntary recall of lorazepam injectable
• Sanofi-Aventis voluntary recall of Admelog insulin injection

May 9, 2023

• Apotex voluntary recall of calcitonin nasal spray

May 3, 2023

• Sun Pharmaceuticals issues voluntary recall of Fyremadel prefilled syringes
• Baxter Healthcare Corporation voluntary recall of Dianeal Low Calcium Peritonial Dialysis Solution
• Baxter Healthcare Corporation voluntary recall of Dianeal PD-2 Peritonial Dialysis Solution

April 27, 2023

• Teva Pharmaceuticals voluntary recall of Fentanyl Buccal tablets

April 26, 2023

• Akon issues voluntary recall of various drug products
• Northwind Pharmaceuticals voluntary recall of Tadalafil 5 mg tablets
• Northwind Pharmaceuticals voluntary recall of Tadalafil 20 mg tablets
• Northwind Pharmaceuticals voluntary recall of Glimepiride 4 mg tablets
• Northwind Pharmaceuticals voluntary recall of Doxazosin 4 mg tablets
• Northwind Pharmaceuticals voluntary recall of Buspirone 7.5 mg tablets
• Northwind Pharmaceuticals voluntary recall of Atorvastatin 10 mg tablets
• Amerisource Health Services voluntary recall of Verapamil 180 mg extended-release tablets
• Northwind Pharmaceuticals voluntary recall of Glimepiride 2 mg tablets

April 21, 2023

• Methapharm Inc. voluntary recall of pantoprazole for injection

April 19, 2023

• Ascend Laboratories, LLC voluntary recall of aripiprazole 20 mg tablets
• Ascend Laboratories voluntary recall of Aripiprazole tablets

April 12, 2023

• Teva Pharmaceuticals recalls montelukast oral granules
• Direct Rx recalls alprazolam tablets

April 5, 2023

• Breckenridge Pharmaceuticals voluntary recall of alprazolam 0.25 mg tablets,
• Breckenridge Pharmaceuticals voluntary recall of alprazolam 0.5 mg tablets,
• Breckenridge Pharmaceuticals voluntary recall of alprazolam 1 mg tablets,
• Endo Pharmaceuticals voluntary recall of calcitonin nasal spray

March 31, 2023

• Camber Pharmaceuticals voluntary recall of atovaquone oral suspension

March 29, 2023

• Direct Rx voluntary recall of simvastatin 40 mg tablets

March 24, 2023

• Direct Rx voluntary recall of finasteride tablets
• Direct Rx voluntary recall of glimepiride 1 mg tablets
• Direct Rx voluntary recall of glimepiride 2 mg tablets
• Direct Rx voluntary recall of glimepiride 4 mg tablets
• Direct Rx voluntary recall of montelukast tablets
• Direct Rx voluntary recall of ropinirole 0.25 mg tablets
• Direct Rx voluntary recall of ropinirole 1 mg tablets
• Direct Rx voluntary recall of simvastatin 10 mg tablets
• Direct Rx voluntary recall of simvastatin 20 mg tablets
• Direct Rx voluntary recall of simvastatin 5 mg tablets

March 23, 2023

• Preferred voluntary recall of Atorvastatin 10mg
• Preferred voluntary recall of Atorvastatin 20mg (30 count bottle)
• Preferred voluntary recall of Atorvastatin 20mg (90 count bottle)
• Preferred voluntary recall of Clopidogrel 75mg
• Preferred voluntary recall of Doxazosin 2mg
• Preferred voluntary recall of Doxazosin 4mg
• Preferred voluntary recall of Finasteride 5mg (30 count bottle)
• Preferred voluntary recall of Finasteride 5mg (90 count bottle)
• Preferred voluntary recall of Glimepiride 2mg
• Preferred voluntary recall of Glimepiride 4mg
• Preferred voluntary recall of Montelukast 10mg (30 count bottle)
• Preferred voluntary recall of Montelukast 10mg (60 count bottle)
• Preferred voluntary recall of Montelukast 10mg (90 count bottle)
• Preferred voluntary recall of Pravastatin 20mg
• Preferred voluntary recall of Rosuvastatin 10mg (30 count bottle)
• Preferred voluntary recall of Rosuvastatin 10mg (90  count bottle)
• Preferred voluntary recall of Rosuvastatin 5mg
• Preferred voluntary recall of Simvastatin 10mg
• Preferred voluntary recall of Simvastatin 20mg (30 count bottle)
• Preferred voluntary recall of Simvastatin 20mg (60  count bottle)
• Preferred voluntary recall of Simvastatin 20mg (90  count bottle)
• Preferred voluntary recall of Simvastatin 40mg (30 count bottle)
• Preferred voluntary recall of Simvastatin 40mg (60  count bottle)
• Preferred voluntary recall of Simvastatin 40mg (90 count bottle)
• Preferred voluntary recall of Simvastatin 80mg
• Preferred voluntary recall of Tadalafil 20mg

March 17, 2023

• Perrigo Company voluntary recall of Gerber Good Start SoothePro formula

March 15, 2023

• Teva Pharmaceuticals voluntary recall of metformin extended-release tablets

March 14, 2023

• Zydus Pharmaceuticals voluntary recall of colchicine tablets

March 10, 2023

• Pharmedica USA voluntary recall of Purely Soothing 15% MSM eye drops
• Becton Dickinson & Company voluntary recall of BD insulin syringes with the BD micro-fine TM IV needle 0.5 mL, 12.7 mm, 28 G
• Becton Dickinson & Company voluntary recall of BD insulin syringes with the BD micro-fine TM IV needle 1 mL, 12.7 mm, 28 G
• Becton Dickinson & Company voluntary recall of BD insulin syringes with the BD micro-fine TM IV needle 1 mL, 12.7 mm, 28 G

March 9, 2023

• Sandoz voluntary recall of lidocaine/prilocaine and aprepitant

March 8, 2023

• Accord voluntary recall of Aripiprazole 2 mg
• Accord voluntary recall of Aripiprazole 5 mg
• Accord voluntary recall of Aripiprazole 10 mg
• Accord voluntary recall of Aripiprazole 15 mg
• Accord voluntary recall of Aripiprazole 20 mg
• Accord voluntary recall of Aripiprazole 30 mg
• Accord voluntary recall of Atorvastatin 10 mg
• Accord voluntary recall of Atorvastatin 20 mg
• Accord voluntary recall of Atorvastatin 40 mg
• Accord voluntary recall of Atorvastatin 80 mg
• Accord voluntary recall of Buspirone 5 mg
• Accord voluntary recall of Buspirone 7.5 mg
• Accord voluntary recall of Buspirone 10 mg
• Accord voluntary recall of Buspirone 15 mg
• Accord voluntary recall of Buspirone 30 mg
• Accord voluntary recall of Clopidogrel 75 mg
• Accord voluntary recall of Doxazosin 1 mg
• Accord voluntary recall of Doxazosin 2 mg
• Accord voluntary recall of Doxazosin 4 mg
• Accord voluntary recall of Doxazosin 8 mg
• Accord voluntary recall of Finasteride 1 mg
• Accord voluntary recall of Finasteride 5 mg
• Accord voluntary recall of Glimepiride 1 mg
• Accord voluntary recall of Glimepiride 2 mg
• Accord voluntary recall of Glimepiride 4 mg
• Accord voluntary recall of Montelukast 10 mg
• Accord voluntary recall of Pravastatin 10 mg
• Accord voluntary recall of Pravastatin 20 mg
• Accord voluntary recall of Pravastatin 40 mg
• Accord voluntary recall of Pravastatin 80 mg
• Accord voluntary recall of Rosuvastatin 5 mg
• Accord voluntary recall of Rosuvastatin 10 mg
• Accord voluntary recall of Rosuvastatin 20 mg
• Accord voluntary recall of Rosuvastatin 40 mg
• Accord voluntary recall of Simvastatin 5 mg
• Accord voluntary recall of Simvastatin 10 mg
• Accord voluntary recall of Simvastatin 20 mg
• Accord voluntary recall of Simvastatin 40 mg
• Accord voluntary recall of Simvastatin 80 mg
• Accord voluntary recall of Tadalafil 2.5 mg
• Accord voluntary recall of Tadalafil 5 mg
• Accord voluntary recall of Tadalafil 10 mg
• Accord voluntary recall of Tadalafil 20 mg
• Accord voluntary recall of Daptomycin 350 mg injection
• Accord voluntary recall of Daptomycin 500 mg injection
• Accord voluntary recall of Dofetilide 125 mcg capsules
• Accord voluntary recall of Dofetilide 250 mcg capsules
• Accord voluntary recall of Dofetilide 500 mcg capsules
• Accord voluntary recall of Glycopyrrolate 0.2 mg/mL
• Accord voluntary recall of Glycopyrrolate 0.4 mg/2mL
• Accord voluntary recall of Glycopyrrolate 1 mg/5mL
• Accord voluntary recall of Glycopyrrolate 4 mg/20mL
• Accord voluntary recall of Phenylephrine 10 mg/mL
• Accord voluntary recall of Phenylephrine 50 mg/5 mL
• Accord voluntary recall of Phenylephrine 100 mg/10 mL
• Accord voluntary recall of Succinylcholine 200 mg/ 10 mL
• Accord voluntary recall of Vigabatrin 500 mg oral solution
• Accord voluntary recall of Pirfenidone 267 mg
• Accord voluntary recall of Pirfenidone 801 mg
• Accord voluntary recall of Ropinirole 0.25 mg
• Accord voluntary recall of Ropinirole 0.5 mg
• Accord voluntary recall of Ropinirole 1 mg
• Accord voluntary recall of Ropinirole 2 mg
• Accord voluntary recall of Ropinirole 3 mg
• Accord voluntary recall of Ropinirole 4 mg
• Accord voluntary recall of Ropinirole 5 mg
• Apotex Corp. voluntary recall of brimonidine ophthalmic solution
• Sagent Pharmaceuticals voluntary recall of heparin injection

March 2, 2023

• Teva Czech Industries voluntary recall of carbidopa/levodopa tablets

February 22, 2023

• Global Pharma initiates recall for Delsam Pharma’s artificial eye ointment
• Rising Pharmaceuticals voluntary recall of warfarin tablets

February 20, 2023

• Reckitt issues voluntary recall of ProSobee Simply Plant-Based Infant Formula

February 15, 2023

• Biocon Pharma issues voluntary recall of posaconazole delated release tablets

February 10, 2023

• B. Braun Medical voluntary recall of 0.9% sodium chloride Excel Plus Container
• B. Braun Medical voluntary recall of 0.9% sodium chloride Excel Plus Container

February 8, 2023

• Sun pharmaceuticals issues voluntary recall of diltiazem extended release capsules

February 2, 2023

• Global Pharma Healthcare issues voluntary recall of artificial tears lubricant eye drops distributed by EzriCare and Delsam Pharma

February 1, 2023

• Hospira issues a voluntary recall of vancomycin injection
• Ascend laboratories issues a voluntary recall of metoprolol succinate ER (extended release) tablets
• GlaxoSmithKline issues voluntary recall of Advil tablets and Liqui Gels
• Preferred Pharmaceuticals voluntary recall of allopurinol tablets,

January 31, 2023

• IBSA Pharma Inc. issues voluntary recall of Tirosint-SOL oral solution

January 25, 2023

• Nephron Pharmaceuticals voluntary recall of sterile water for injection
• Nephron Pharmaceuticals voluntary recall of 0.9% sodium chloride for injection
• Lannett Company voluntary recall of triamterene hydrochlorothiazide capsules
• Akorn Inc. voluntary recall of a multitude of prescription and over-the-counter ophthalmic products

January 24, 2023

• Nephron Pharmaceuticals voluntary recall of asthmanefrin racepinephrine inhalation solution
• Nephron Pharmaceuticals voluntary recall of S2 racepinephrine inhalation solution

January 9, 2023

• Lupin pharmaceuticals issues voluntary recall of rifampin capsules

January 4, 2023

• Apotex Corp issues a voluntary recall of timolol ophthalmic solution

December 23, 2022

• Accord Healthcare issued a voluntary recall of daptomycin for injection
• Aurolife Pharma issues voluntary recall of glycopyrrolate tablets

December 22, 2022

• Hospira issued a voluntary recall of vancomycin injection

December 21, 2022

• Exela Pharma issues voluntary class I recall of sodium bicarbonate injection 8.4%
• Lupin pharmaceuticals issues voluntary recall of quinapril tablets

November 30, 2022

• Heritage Pharmaceuticals voluntary class II recall of Desmopressin tablets

November 16, 2022

• Mylan voluntary Class I recall of Octreotide

November 2, 2022

• AuroMedics voluntary class II recall of fondaparinux injection

October 26, 2022

• Aurobindo voluntary class II recall of quinapril hydrochlorothiazide tablets
• Abbott voluntary recall of Similac 360 Total Care Ready-to-Feed Liquid products

October 25, 2022

• Mylan voluntary recall of Octreotide injection

October 14, 2022

• Abbott voluntary recall of Similac 360 Total Care Ready-to-Feed Liquid products

October 5, 2022

• Sun Pharmaceuticals voluntary class III recall of esomeprazole capsules
• Akorn Inc voluntary class II recall of rifampin capsules
• Viatris Inc voluntary class II recall of ampicillin for injection

October 4, 2022

• Pfizer voluntary class II recall of aminophylline injection

September 29, 2022

• Eugua US LLC issues voluntary consumer level recall of acyclovir injection

September 28, 2022

• CIPLA voluntary class II recall of budesonide inhalation suspension

September 27, 2022

• Golden State Medical Supply, Incorporated issues voluntary recall of clopidogrel 75 mg tablets and atenolol 25 mg tablets

September 21, 2022

• Lupin pharmaceuticals voluntary class II recall of Lisinopril 10 mg tablets

September 14, 2022

• Plastikon Healthcare voluntary class II recall of CORRECTDOSE Children’s Pain relief and Fever reducer
• Plastikon Healthcare voluntary class II recall of CORRECTDOSE Children’s Cough and Chest Congestion DM
• Major Pharmaceuticals voluntary class II recall of acetaminophen solution cups

September 7, 2022

• Akorn, Inc. voluntary class II recall of Lidocaine Hydrochloride Jelly 2%
• Akorn, Inc. voluntary class III recall of timolol ophthalmic solution

September 6, 2022

• Plastikon Healthcare voluntary class II recall of diphenhydramine oral solution
• Plastikon Healthcare voluntary class II recall of CORRECTDOSE Children’s Allergy relief
• Mother’s Touch Infant Formula consumer level recall

August 24, 2022

• Akron Pharma Inc voluntary class III recall of over-the-counter acetaminophen
• Akorn Pharmaceuticals voluntary class II recall for prednisolone oral solution
• Nephron voluntary class II recall of ketorolac injection

August 22, 2022

• Hospira issues voluntary recall for propofol injectable emulsion

August 18, 2022

• Akorn, Inc. voluntary class II recall of TheraTears Extra 0.25% Lubricant Eye Drops

August 17, 2022

• Amneal Pharmaceuticals voluntary class II recall for divalproex extended-release tablets
• Glenmark Pharmaceuticals voluntary class II recall of telmisartan and hydrochlorothiazide tablets
• Baxter Healthcare Corporation voluntary class II recall for acetaminophen injection 10mg/mL

August 10, 2022

• Lyons Magnus expanded voluntary consumer level recall of various Kate Farms products and Abbott PediSure/Ensure Harvest
• Glenmark Pharmaceuticals Inc voluntary class III recall of tacrolimus ointment
• Tolmar Inc voluntary class II recall of naftifine 1% gel
• Teva Pharmaceuticals voluntary class II recall of Matzim LA

August 8, 2022

• AvKARE Inc voluntary class III recall of lamotrigine tablets

August 4, 2022

• Plastikon Healthcare Expands Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide /Aluminum Hydroxide /Simethicone Oral Suspension

August 3, 2022

• Dr. Reddy’s Laboratory LLC voluntary class II recall of lansoprazole tablets
• Mylan Pharmaceuticals Inc voluntary class I recall of insulin glargine prefilled pens
• Jubilant Cadista Pharmaceuticals voluntary class II recall of irbesartan tablets
• Lyons Magnus voluntary consumer level recall of Kate Farms Pediatric Standard 1.2 Vanilla formula

July 18, 2022

• Nephron Sterile Compounding Center LLC voluntary class II recall of epinephrine injection 0.1 mg/10mL syringes

July 13, 2022

• Glenmark Pharmaceuticals, Inc., voluntary Class III recall of Mometasone Furoate Topical Solution

July 6, 2022

• Akcea Therapeutics, Inc., voluntary Class I recall of Tegsedi injection
• Buzzagogo, voluntary Class I recall of Allergy Bee Gone for Kids Nasal Swab Remedy
• PD-Rx Pharmaceuticals Inc, voluntary Class II recall of Losartan Potassium tablets
• Mylan Pharmaceuticals Inc. issues a consumer-level recall of Insulin Glargine (Insulin glargine-yfgn) Injection Pens

June 28, 2022

• BRP Pharmaceuticals issues a consumer-level recall of Morphine Sulfate Extended-Release Tablets

June 22, 2022

• Lupin Pharmaceuticals Inc. issues voluntary Class II recall of Zileuton Extended-Release Tablets, 600 mg
• Sun Pharmaceutical Industries Inc. issues voluntary class II recall of medroxyprogesterone acetate

June 21, 2022

• Vi-Jon, LLC issues voluntary consumer level recall of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor

June 15, 2022

• Novartis Pharmaceuticals Corporation issues voluntary Class III recall of Xiidra (lifitegrast ophthalmic solution)

June 8, 2022

• Plastikon Healthcare LLC, voluntary consumer-level recall of Liquid Unit Dose Cups
• Lupin Pharmaceuticals, Voluntary Class II recall of losartan-hydrochlorothiazide tablets, June 8, 2022
• Nephron Sterile Compounding Center, voluntary Class II recall of syringes and IV bags containing various compounds for injection

May 25, 2022

• Plastikon Healthcare, LLC, voluntary Class II recall of Acetaminophen oral solution 650mg/20.3mL cup
• Pfizer Inc, voluntary Class II recall of Accupril 20mg tablets, May 25, 2022

May 23, 2022

• Teva Pharmaceuticals, voluntary consumer-level recall of Anagrelide Capsules

May 18, 2022

• Amgen Inc, voluntary Class II recall of Mvasi injection
• Sun Pharmaceutical Industries, voluntary Class III recall of Bupropion hydrochloride tablet (SR) 200mg
• Fagron Inc, voluntary Class I recall of SyrSpend SF Suspending Base

May 11, 2022

• McKesson Corporation dba McKesson Drug Company issues Class II voluntary recall of Lidocaine 4% Solution
• Lupin Pharmaceuticals and Macleods Pharma, voluntary Class II recall of losartan potassium and losartan potassium-hydrochlorothiazide tablets
• Torrent Pharma Inc voluntary Class II recall of pantoprazole sodium delayed-release tablets

May 5, 2022

• Teva Pharmaceuticals USA Inc issues voluntary class II recall of Lidocaine 2.5% and Prilocaine 2.5% cream

May 4, 2022

• Mylan Pharmaceuticals, voluntary Class I recall of insulin glargine
• Glenmark Pharmaceuticals Inc., USA issues voluntary Class II recall of Zonisamide 25 mg Capsules
• Glenmark Pharmaceuticals Inc., USA issues voluntary Class II recall of Zonisamide 50 mg Capsules
• Glenmark Pharmaceuticals Inc., USA issues voluntary Class II recall of Zonisamide 100 mg Capsules

April 29, 2022

• Fagron Inc. issues voluntary recall of SyrSpend SF Cherry

April 27, 2022

• Mylan Pharmaceuticals issues voluntary Class II recall of rifampin for injection

April 26, 2022

• Drug Depot, LLC issues voluntary recall of compounded “gonadorelin acetate,” “testosterone cypionate in grapeseed oil,” “testosterone cypionate/anastrozole in grapeseed oil,” “testosterone cypionate/DHEA in grapeseed oil,” and “testosterone cypionate/propionate in sesame seed oil”

April 13, 2022

• Adamis Pharmaceuticals Corporation issues voluntary class I recall of Symjepi
• Pfizer Inc. issues voluntary class II recall of Accuretic
• Pfizer Inc. issues voluntary class II recall of Quinapril-hydrochlorothiazide (generic Accuretic)
• Vitae Enim Vitae Scientific, Inc. issues voluntary class II recall of Phenobarbital sodium injection

April 12, 2022

• Mylan Pharmaceuticals Inc. issues voluntary consumer level recall of Insulin Glargine (Insulin glargine-yfgn) Injection

April 6, 2022

• Dr. Reddy’s Laboratories, Inc. issues voluntary class III recall of Atorvastatin
• Fresenius Kabi issues voluntary class I recall of Sodium Acetate Injection
• Drug Depot Inc issues voluntary class II recall of Gonadorelin

March 30, 2022

• Blaine Labs Inc. issues voluntary class I recall of Revitaderm Wound Care Gel
• Athenex Pharma Solutions voluntary class II recall for norepinephrine bitartrate injection

March 24, 2022

• Plastikon Healthcare issues voluntary recall of Milk of Magnesia Oral Suspension, Magnesium Hydroxide/Aluminum Hydroxide/Simethicone, and Acetaminophen, Unit Dose Cups

March 22, 2022

• Pfizer voluntarily recalls Accuretic (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets
• Sandoz voluntarily recalls Orphenadrine Citrate 100 mg Extended Release Tablets
• Adamis Pharmaceuticals Corporation Issues Voluntary Recall of SYMJEPI (Epinephrine) Injection

March 9, 2022

• Macleods Pharmaceuticals voluntarily recalls amlodipine/olmesartan tablets
• Macleods Pharma USA voluntary class II recall of olanzapine tablets
• Par Pharmaceutical is voluntarily recalling alprazolam tablets

March 7, 2022

• Fresenius Kabi USA voluntarily recalls sodium acetate injection

March 3, 2022

• B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection

March 2, 2022

• Perrigo Company is voluntarily recalling nasal sprays containing oxymetazoline

February 28, 2022

• Abbott is voluntarily recalling Similac PM 60/40

February 23, 2022

• Lannett Company issued voluntary class II recall of diazepam oral solution
• ANI Pharmaceuticals issued voluntary class II recall of alprazolam tablets
• Aurobindo Pharma USA Inc issued voluntary class II recall of moxifloxacin ophthalmic solution

February 17, 2022

• Abbott initiates a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare

February 9, 2022

• Unable to retrieve resource (PDF)
• Unable to retrieve resource (PDF)
• Antacid Tablets Manufactured by Ultra-Tab Laboratories Class II Recall
• Acetaminophen Products Manufactured by Ultra-Tab Laboratories Class II Recall

February 2, 2022

• Teva Pharmaceuticals USA voluntarily class III recall of Mimvey
• Alkem Laboratories Ltd issues voluntary class II recall for Metoprolol Succinate ER (extended release) 25 mg tablets
• Alkem Laboratories Ltd issues voluntary class II recall for Metoprolol Succinate ER (extended release) 50 mg tablets
• Edge Pharma is voluntarily recalling all lots of all drugs it compounded and dispensed

January 28, 2022

• AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection

January 26, 2022

• Medique Products is voluntarily recalling acetaminophen-aspirin-caffeine tablets sold as Extra Strength Headache and Medique Pain-Off tablets
• Teva Pharmaceuticals is voluntarily recalling brinzolamide eye drops

January 19, 2022

• Torrent issues a voluntary class II recall of carbamazepine tablets

January 18, 2022

• Mylan pharmaceuticals issues a voluntary recall of Semglee

January 12, 2022

• Lohxa LLC is voluntarily recalling Senna Syrup

January 7, 2022

• Moor Herbs recalls “Angel Formula” infant formula

January 5, 2022

• Lupin Pharmaceuticals Inc is voluntarily recalling oxycodone tablets
• Ascend Laboratories is voluntarily recalling cefixime capsules

December 30, 2021

• Taro Pharmaceuticals USA issues voluntary recall of clobetasol ointment 0.05%

December 29, 2021

• Teva Pharmaceuticals USA, Inc. issues a class II recall for Penicillin V Potassium for Oral Solution
• Efficient Laboratories issues Class II recall of Rompe Pecho OTC cold and flu medications
• Fexofenadine 60 mg tablets class II recall
• Moxifloxacin 1 mg/mL solution for intracameral injection class II recall

December 28, 2021

• Viona Pharmaceuticals Inc., issues voluntary recall of metformin extended release (ER) tablets

December 27, 2021

• Padagis issues consumer level voluntary recall for nitroglycerin lingual spray

December 22, 2021

• SOLA Pharmaceuticals Preferred Pharmaceuticals, Inc. voluntary class II recall of Diclofenac Sodium Topical Solution, 1.5%

December 15, 2021

• Apollo Care voluntary class II recall of intravenous vancomycin
• Ascent Pharmaceuticals, Inc. issued a voluntary class II recall for hydrocodone acetaminophen 10/325 mg tablets

December 7, 2021

• Teligent Pharma Inc. issues a voluntary recall of lidocaine HCL topical solution 4% –
• Edge Pharma, LLC issues voluntary nationwide recall of all drug products compounded at Edge Pharma, LLC

December 1, 2021

• Bryant Ranch Prepack issues a class III voluntary recall of butalbital, acetaminophen, and caffeine tablets
• Sandoz issues nationwide recall of one lot of enoxapiarin sodium injection USP 40mg/0.4mL due to temperature excursion during shipping

November 24, 2021

• Bayer issues a voluntary class I, II recalls for OTC Antifungal Sprays
• Teva Pharmaceuticals issues a voluntary class II recall for clonidine transdermal patches
• Amneal Pharmaceuticals issues a voluntary class II recall for fluocinolone acetonide topical oil

November 23, 2021

• Teligent Pharma Inc. issues a class II voluntary recall of diclofenac sodium topical solution

November 22, 2021

• Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

November 17, 2021

• Precision Dose Inc issued a voluntary class II recall for acetaminophen oral suspension
• Ascend Laboratories issued a voluntary class II recall for cefizime capsules

November 10, 2021

• Merck & Co, Inc Issues a voluntary nationwide class I recall for Cubicin 500 mg vials
• Bryant Ranch Prepack issues a voluntary nationwide class I recall for methocarbamol 500 mg tablets
• Dr Reddy’s Laboratories Inc issues a voluntary nationwide class II recall for Ezetimibe and Simvastatin Tablets

October 21, 2021

• Merck Issues Voluntary Nationwide Recall of Cubicin

October 20, 2021

• Strides Pharma Inc and SSM Health Care St Louis Recall of Potassium Chloride products
• Class I recall for Eli Lilly & Company’s Glucagon Emergency Kit for Low Blood Sugar

October 16, 2021

• Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500 mg bott

October 14, 2021

• Eye Solution Recalled
• Glycopeptide Antibacterial Treatment Under Class
• Vertigo Drug Recal

September 29, 2021

• Class II Recall Notification: metoprolol tartrate tablets manufactured by Aurobindo Pharma USA Inc
• Chlorzoxazone Tablets Manufactured by Glenmark Pharmaceuticals Inc.
• Promethazine Syrup manufactured by Morton Grove Pharmaceuticals, Inc.
• Valproic Acid Oral Solution (250 mg/5 mL) manufactured by Morton Grove Pharmaceuticals, Inc.

September 27, 2021

• Class II Recall Notification: morphine sulfate vials manufactured by Fresenius Kabi USA

September 26, 2021

• Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency

September 24, 2021

• Class III Recall Notification: CVS Health Daytime Severe Cold & Flu Relief (acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride) by New Vision Pharmaceuticals
• Class II Recall Notification: Valproic Acid Oral Solution by American Health Packaging

September 23, 2021

• Opioid Analgesic Recalled

September 22, 2021

• IntegraDose Compounding Services, LLC Issues Voluntary Nationwide Recall of Cefazolin Injection Products Due to a Lack of Sterility Assurance
• Class II Recall Notification: Betamethasone Dipropionate Lotion manufactured by Hi-Tech Pharmacal and distributed by Akorn, Inc.

September 17, 2021

• Compounded Products Intended to be Sterile by Greenpark Compounding Pharmacy: CDER Alert – FDA Alerts Patients and Health Care Professionals Not to Use
• Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content

September 15, 2021

• Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination

September 10, 2021

• OTC Pain Reliever Under Recall
• Muscle Relaxant Recall Spans Three Labelers
• Blood Thinner Recalled

September 8, 2021

• ICU Medical Issues a Voluntary Nationwide Recall of Aminosyn II 15%, An Amino Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter
• Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (Vancomycin Hydrochloride for Oral Solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit

September 3, 2021

• Class I Recall for Antifungal Medication
• Class I Recall for Contaminated IV Bags
• Mislabeling of Drug Autoinjector Prompts Recall

September 1, 2021

• Class II Recall Notification: Erythromycin Topical Solution 2% 60 mL bottle manufactured by Teligent

August 30, 2021

• Cardinal Health Issues Nationwide Recall of Select Monoject™ Flush Prefilled Saline Syringes
• Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due to Super Potency
• Class II Recall Notification: COMBIPATCH® manufactured by Noven Pharmaceuticals, Inc.

August 26, 2021

• Muscle Relaxant Recalled
• Beta Blocker Recalled

August 18, 2021

• Accu-Chek® Aviva Plus and Accu-Chek® SmartView Test Strips – Potential for Open Vials

August 17, 2021

• Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N- Nitroso Varenicline Content

August 13, 2021

• Paralytic Drug Recalled
• Smoking Cessation Drug Recalled

August 12, 2021

• Consumer-Level Withdrawal Notification: Gamunex®-C 10% manufactured by Grifols Therapeutics (See: “VOLUNTARY WITHDRAWALS OF GAMUNEX-C 10% LOTS”)

August 11, 2021

• SterRx, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL Due to Microbial Contamination

August 9, 2021

• Able Groupe Recalling Products Labeled as Infant Formula Formulas Have Insufficient Iron Levels as Per Requirements for Infant Formula in The U.S., and Products Do Not Meet Other FDA Requirements

August 6, 2021

• Bulk Estriol Recalled
• KVK Tech Inc., Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5mL Due to Temperature Abuse

July 29, 2021

• Compounded Medications Recalled

July 19, 2021

• Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content

July 16, 2021

• Opioid Dependence Drug Recalled for Subpotency
• Over 88,000 Anti-Inflammatory Injections Recalled
• Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

July 12, 2021

• Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance

July 2, 2021

• FDA alerts health care professionals and patients to a voluntary recall of varenicline (Chantix) to the warehouse level
• Diabetes Tablet Recalled for NDMA

July 1, 2021

• Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

June 27, 2021

• Consumer-Level Withdrawal Notification: Gamunex® C-10 manufactured by Grifols

June 21, 2021

• Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings

June 17, 2021

• UltiCare Pen Needles 6mm, 31G x 1/4″ manufactured by UltiMed, Inc.

June 16, 2021

• Sodium Chloride 0.9%, USP, 1000 mL manufactured by Fresenius Medical Care North America: Class II Recall

June 14, 2021

• Metformin HCl Extended-Release Tablets – USP 750 mg by Viona Pharmaceuticals

June 8, 2021

• Class II Recall Notification: BusPIRone Hydrochloride 15 mg tablets manufactured by Oxford Pharmaceuticals
• Class II Recall Notification: Micardis Tablets manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

June 7, 2021

• Class I Recall Issued for Subpotent Thyroid Medication

June 2, 2021

• ADHD Patches Recalled

May 27, 2021

• Subpotent Antibiotic Recalled
• Class II Recall Notification: Guardian Sensor (3), GS3 5PK 2L US, Medtronic REF: MMT-7020A
• Class II Recall Notification: Guardian Sensor (3), GS3 5PK US, Medtronic REF: MMT-7020LA
• Class II Recall Notification: Medtronic REF: MMT-7008A, Enlite Glucose Sensor, ENLITE PLUS 5PK 23L 1CL, ENLT PLUS 5PK 2L 1CL PR
• Class II Recall Notification: Guardian Sensor (3), GS3 5PK US GC, Medtronic REF: MMT-7020GA

May 19, 2021

• Class II Recall Notification: Delflex Peritoneal Dialysis Solution with 1.5% Dextrose, LM/LC, packaged in a case containing 2 x 6 Liter bags, Fresenius Medical Care, North America

May 5, 2021

• Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
• Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
• Preferred Pharmaceuticals, Inc. Issues a Voluntary Recall of Select Bottles of Cephalexin for Oral Suspension
• PD-Rx Pharmaceuticals, Inc. Issues a Voluntary Recall of Select Bottles of Losartan Potassium Tablets

April 30, 2021

• Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency

April 28, 2021

• Ophthalmic Solution Recalled
• Topical Steroid Recalled
• Transdermal Hormone Recalled

April 27, 2021

• Consumer-Level Recall of One Lot of Gamunex-C 10%

April 22, 2021

• Class II Recall Notification: Itraconazole Capsules, 100mg Manufactured by Jubilant Cadista Pharmaceuticals, Inc.
• Class II Recall Notification: Cefprozil for Oral Suspension USP, 250mg/5mL by Lupin Limited

April 21, 2021

• Class II Recall Notification: Riomet (Metformin Hydrochloride Oral Solution) 500 mg/5 mL, Cherry Flavor, 16 fl. oz., 473 mL Bottles manufactured by Mikart, LLC

April 14, 2021

• Class II Recall Notification: Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion) manufactured by Cosette Pharmaceuticals, Inc.
• Class II Recall: Neomycin Sulfate Tablets, USP 500mg by X-Gen Pharmaceuticals Inc.
• Class II Recall: Ganirelix Acetate Injection, 250mcg/0.5mL by Sun Pharmaceuticals Inc.

April 5, 2021

• A-S Medication Solutions Issues Voluntary Nationwide Recall of Acetaminophen Extra Strength Tablets Contained in Health Essentials Kits Due to Mislabeling

April 1, 2021

• Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg due to trace amounts of Quetiapine Fumarate

March 25, 2021

• Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up
• Consumer-Level Withdrawal Notification: Gamunex®-C 10% manufactured by Grifols
• Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization

March 16, 2021

• Class II Recall Notification: Progesterone 200 mg capsules manufactured by Dr. Reddy
• Class II Recall Notification: Famotidine 40 mg tablets manufactured by Aurobindo

March 12, 2021

• Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL Due to Potential Lack of Sterility Assurance

March 10, 2021

• Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Spironolactone 25 mg and 50 mg Tablets Due to Mislabeling with the Incorrect Strength (Revision to Press Release with Same Title Dated 3/9/2021. Revision Includes Number of Bottles Impacted by Recall)

March 3, 2021

• Class I Recall Notification: Cisatracurium Besylate Injection, 10 mg per 5 mL manufactured by Meitheal Pharmaceuticals, Inc.
• Class II Recall Notification: Imatinib Mesylate 100 mg Tablets, 90 Count Bottle manufactured by Dr. Reddy’s

February 26, 2021

• Vertigo Tablets Recalled in Two States
• Dr. Reddy’s Recalls Prescription Drug Blister Packages
• Voluntary Withdrawal of Two Lots of Gamunex-C 10% (Lot Number A1GLE01532) (Lot Number A1GLE01542)

February 13, 2021

• BRP Spironolactone tablets Consumer-Level Recall

February 12, 2021

• Pain Injection Recalled
• More Diabetes Tablets Recalled

February 2, 2021

• Class II Recall: Nortriptyline HCl Capsules by Taro Pharmaceuticals U.S.A., Inc.
• Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings
• Class I Recall Notification: Ketorolac Tromethamine 30 mg/1 mL Injection manufactured by Fresenius Kabi USA, LLC

January 28, 2021

• Antibiotic Recalled
• Ophthalmic Injection Recalled

January 27, 2021

• Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection, USP 10mg per 5mL Due to Mislabeling

January 15, 2021

• Pain Injections Recalled
• Additional Recalls for Antibiotic
• Anesthesia Drug Recalled

January 8, 2021

• Combination Antibiotic Recalled Over Sterility Concerns
• Pain Medication Recalled
• Antibiotic Recalled

January 4, 2021

• Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

December 31, 2020

• Precision Dose, Inc. Issues Voluntary Nationwide Recall of Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12%, 15mL Due to Microbial Contamination

December 20, 2020

• Anesthetic Injection Recalled
• Chronic Kidney Disease Drug Recalled
• Antianxiety Agent Recalled

December 29, 2020

• Sunstar Americas Inc. Expands Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

December 23, 2020

• Antidepressant Under Class I Recall After Product Mix-Up
• Diluent Recall Grows
• GERD Drug Recalled

December 18, 2020

• Sedative Recall Designated Class I

December 17, 2020

• Leukemia Drug Recalled
• Chemo Injection Recalled
• Chemotherapy Tablets Recalled
• Chemotherapy Drug Recalled

December 10, 2020

• Antipsychotic Recalled

December 9, 2020

• AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets Due to Product Mix-Up
• Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules, USP Due to Dissolution Test Failure

December 3, 2020

• Antidepressant Recalled
• Anticonvulsant Recalled

December 2, 2020

• MPM Medical LLC Issues Voluntary Nationwide Recall of Regenecare HA Hydrogel Due to Burkholderia cepecia Contamination

November 25, 2020

• Diluent Recalled
• Antipsychotic Recalled
• Pain Tablets Recalled
• Diabetes Drug Recalled

November 19, 2020

• Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

November 13, 2020

• Multiple Firms Issue New Recalls for Diabetes Drug
• Prescription-Strength Heartburn Drug Recalled

November 9, 2020

• Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

November 6, 2020

• Hypertension Drug Recalled
• Diabetes Med Recalled
• Skin Cream Recalled

November 3, 2020

• Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

November 2, 2020

• Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

October 28, 2020

• Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

October 17, 2020

• Antacid Tablets Recalled Over NDMA Impurity

October 16, 2020

• Appetite Suppressant Recalled

October 8, 2020

• Pain Patches Recalled

October 5, 2020

• Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)

September 23, 2020

• Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

September 21, 2020

• FDA Alerts of Perrigo's voluntary albuterol inhaler recall

September 18, 2020

• Subpotent Antibiotic Recalled
• Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

September 9, 2020

• Homeopathic Tablets Recalled

September 3, 2020

• Class I Recall for Anticoagulant
• Antibiotic Recalled
• Narcotic Pain Injection Recalled
• Consumer-Level Recall of Nature-Throid® and WP Thyroid® Tablets Manufactured by RLC Labs®

September 1, 2020

• Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

August 28, 2020

• Diuretic Recalled
• Anticonvulsant Recalled

August 26, 2020

• Sanofi-Aventis U.S. LLC
  • Elitek for Injection recall
• Lannett Company, Inc.
  • Prednisone recall
• The Calvin Scott & Company:
  • Thyroid recalls
  • Phentermine recalls
  • Phendimetrazine recalls

August 21, 2020

• Class I Recall of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200mcg/50mL, 50mL Dose Bottle Manufactures by Fresenius Kabi USA, LLC

August 19, 2020

• SCA Pharmaceuticals (SCA) Is Issuing a Voluntary Nationwide Recall of Heparin Sodium Compounded Products Due to Incorrect Preservative (Benzyl Alcohol)
• Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

August 14, 2020

• Anesthetic Injection Recalled
• Class I Recall for Antibiotic Injection

August 7, 2020

• Blood Pressure Med Recalled

August 6, 2020

• Ferring US Issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency

July 29, 2020

• Superpotent Antibiotic Recalled

July 24, 2020

• Chronic Kidney Disease Drug Recalled

July 23, 2020

• Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

July 14, 2020

• CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets

July 9, 2020

• Two More Firms Recall Diabetes Drug
• Two Children’s Meds Recalled
• Braun Recalling Heparin Products On July 9, 2020, CVS Caremark Mail Service received a consumer-level withdrawal notice from McKesson regarding Heparin Sodium in 5% Dextrose Injection manufactured by B Braun Medical Inc. This withdrawal was issued as part of ongoing changes which BBMI is performing to ensure their Heparin in Dextrose products meet USP requirements for Anti-Factor IIa potency throughout the labeled product shelf-life, BBMI is incorporating revisions to internal manufacturing requirements. Out of an abundance of caution, BBMI is withdrawing non-expired batches of those Heparin in Dextrose products which were produced prior to implementation of these changes. This withdrawal affects select Heparin Sodium in 5% Dextrose Injection products.
• Osteoarthritis Injection Recalled

July 8, 2020

• Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to The Presence of Particulate
• Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

July 6, 2020

• Granules Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

July 2, 2020

• Diabetes Drug Recall Grows
• Label Mistake Prompts Antipsychotic Recall
• Major Pharmaceuticals Issues a Consumer-Level Recall of Metformin Extended-Release Tablets On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10x10 Unit Dose with NDC #00904-5794-61. The recall was issued due to one lot of Metformin being tested and showed results for NDMA levels in excess of the Acceptable Daily Intake Limit. This recall affects lot number T-02134 with expiration date 09/2020.

June 26, 2020

• Three Firms Recall Diabetes Drug
• Chemotherapy Injection Recalled

June 19, 2020

• GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children's Robitussin® Honey Cough and Chest Congestion DM and Children's Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings
• Class I, II Recalls for Pain Injection
• Antibiotic Pills Recalled

June 17, 2020

• Fresenius Kabi Recalls Anti-Inflammation Drug Ketorolac

June 12, 2020

• Class I Recall for Thyroid Tablets
• Stimulant Recalled
• Antibiotics Recalled

June 11, 2020

• Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of One Lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg Due to the Detection of N-Nitrosodimethylamine (NDMA)
• AvKARE Issues Consumer-Level Recall of Metformin Hydrochloride Extended-Release 500mg and 750mg Tablets

June 5, 2020

• Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
• Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)

June 3, 2020

• OTC Pain Relief Patches Recalled
• Antibiotic Tablets Recalled

June 2, 2020

• Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, Due to Detection of N-Nitrosodimethylamine (NDMA) Impurity

June 1, 2020

• FDA alerts patients and health care professionals of Amneal and Impax Laboratories epinephrine auto-injector device malfunctions

May 28, 2020

• Gout Drug Recalled

May 27, 2020

• Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)

May 22, 2020

• Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency

May 15, 2020

• Emergency Allergy Auto-Injectors Recalled

May 12, 2020

• MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug

May 11, 2020

• MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug

May 8, 2020

• ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP Due to the Presence of Particulate Matter
• Class I Recall Issued for Intravenous Antibiotic
• CU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP Due to the Presence of Particulate Matter
• Antacid Recalled

May 1, 2020

• Hypertension Drug Recalled
• Antibiotic Recalled
• ADHD Patches Recalled for Defective Delivery Systems

April 29, 2020

• GSK Consumer Healthcare Recalls Benefiber Healthy Shape Prebiotic Fiber Supplement and Benefiber Prebiotic Fiber Supplement Due to Possible Plastic Contamination from the Bottle Cap

April 24, 2020

• Pain Meds Recalled
• Repackaged Pain Relievers Recalled
• Blood Pressure Drug Recalled

April 21, 2020

• Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush Syringes
• B. Braun Medical Inc. Issues Voluntary Nationwide Recall of One (1) Lot of Ceftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex Container Due to Out-of-Specification Results for High Molecular Weight Polymers
• Trividia Health, Inc. Issues Nationwide Voluntary Recall for an Isolated TRUE METRIX AIR Blood Glucose Meter with Serial Number TA1548753

April 20, 2020

• Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
• Avet Pharmaceuticals Voluntarily Issues Recall of 50mg Losartan Potassium Tablets Due to Failed Dissolution Specifications
• Avet Pharmaceuticals Voluntarily Issues Recall of 100mg Losartan Potassium Tablets Due to Failed Dissolution Specifications

April 17, 2020

• Avet Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Tetracycline HCl Capsules USP, 250 mg and 500 mg Due to Failed Dissolution Specifications

April 15, 2020

• Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Nizatidine Oral Solution, 15 mg/mL, Due to Potential Levels of N-nitrosodimethylamine (NDMA) Impurity Amounts Above the Levels Established by FDA
• International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Clopidogrel Tablets USP, 75 mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A

April 9, 2020

• ACE Inhibitor Recalled
• Ulcer Medication Recalled

April 3, 2020

• OTC Pain Relief Products Recalled
• Bronchodilator Recalled

April 1, 2020

• All Ranitidine Products (Zantac): Press Release - FDA Requests Removal

March 27, 2020

• Dr. Reddy's Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
• Antibiotic Recalled
• Stimulant Patches Recalled

March 24, 2020

• FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration

March 20, 2020

• Antacid Solution, Tablets Recalled
• Pain Reliever Recalled
• Parkinson Drug Recalled

March 13, 2020

• Ulcerative Colitis Drug Recalled
• Corticosteroid Spray Recalled

March 5, 2020

• Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates

February 28, 2020

• Antidiuretic Tablets Recalled
• Antimuscarinic Recalled

February 27, 2020

• American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity

February 24, 2020

• ADHD Stimulant Recalled

February 21, 2020

• Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml Due to Possible Underdosing or Overdosing
• Cholesterol, Blood Pressure Med Recalled
• Antibiotic Recalled

February 14, 2020

• Nearly 30,000 Bottles of a Statin Recalled
• Antidiuretic Recalled

February 13, 2020

• Belviq, Belviq XR (lorcaserin) by Eisai: Drug Safety Communication - FDA Requests Withdrawal of Weight-Loss Drug

January 31, 2020

• Antacid Recalls Grow
• Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination

January 27, 2020

• Denton Pharma, Inc. dba Northwind Pharmaceuticals Ranitidine Tablet Recall

January 22, 2020

• Sun Pharma recalls batches of anti-migraine drug, testosterone injection in US

January 17, 2020

• FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility

January 10, 2020

• Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles

January 9, 2020

• More Antacid Recalls Announced

January 9, 2020

• Acne Medication Recalled

January 9, 2020

• Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited

January 8, 2020

• Appco Pharma LLC Issues Voluntary Nationwide Recall of Ranitidine Hydrochloride Capsules 150 mg and 300 mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

January 8, 2020

• Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity

December 30, 2019

• Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Mirtazapine Tablets Lot Number 03119002A3 Due to Label Error on Declared Strength

December 26, 2019

• FDA MedWatch: All Manufactured Products by Mavidon – Recall

December 20, 2019

• Lannett Issues Voluntary Nationwide Recall of Levetiracetam Oral Solution, 100mg/Ml Due to Microbial Contamination

December 20, 2019

• Antibiotic Injection Recalled

December 20, 2019

• Flu Drug Recalled

December 20, 2019

• Hypoglycemia Injection Recalled

December 20, 2019

• Antidepressant Recalled

December 18, 2019

• Consumer-Level Withdrawal Notification: Gamunex®-C 10% manufactured by Grifols

December 18, 2019

• Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity

December 17, 2019

• FDA MedWatch: CrossCath Support Catheters by Cook Medical- Class I Recall

December 6, 2019

• Additional Antacids Pulled Over NMDA Contamination

November 27, 2019

• Antiviral Drug Recalled

November 25, 2019

• Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity

November 21, 2019

• Cough Medicine Recalled

November 21, 2019

• Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA)

November 15, 2019

• Anxiety Medication Recalled

November 15, 2019

• Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Ranitidine Hydrochloride 150mg and 300mg Capsules (Manufactured by Novitium Pharma LLC) Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

November 14, 2019

• Recall Spans OTC, Prescription Antacids Sold Under Various Brands

November 12, 2019

• Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg

November 9, 2019

• Blood Thinner Recalled

November 8, 2019

• American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity

November 8, 2019

• Pain Med Recall Includes Children’s OTC Product

November 7, 2019

• Gamunex-C 10% Consumer Level Withdrawal

October 25, 2019

• Folic Acid Injection Recalled

October 25, 2019

• Reflux Drug Recalled

October 25, 2019

• ADHD Drug

October 25, 2019

• Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance

October 25, 2019

• Novitium Pharma Issues Voluntary National Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

October 25, 2019

• Lannett Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/ml due to an Elevated Level of the Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

October 25, 2019

• Diabetes Drug Recalled

October 23, 2019

• Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the Product

October 23, 2019

• Dr. Reddy’s Confirms its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market

October 23, 2019

• Sanofi Provides Update on Precautionary Voluntary Recall of Zantac OTC in U.S.

October 19, 2019

• Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby Powder in the United States

October 17, 2019

• Hormone Tablets Recalled

October 16, 2019

• Viatrexx Bio Incorporated Issues Voluntary Nationwide Recall of Sterile Injectables

October 11, 2019

• Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of all Sterile Compounded Drug Products Due to a Lack of Sterility Assurance

October 10, 2019

• Eye Solution Recalled

October 9, 2018

• ICU Medical Issues a Voluntary Nationwide Recall of Certain Lots of Plum and Sapphire Microbore Infusion Sets with Inline Filters

October 4, 2018

• Anesthetic Jelly Recalled

September 26, 2019

• B. Braun Medical Inc. Issues Voluntary Nationwide Recall of one lot of one catalog item number of an Infusomat® Space Volumetric Infusion Pump Administration Set, Due to Potential Leakage

September 25, 2019

• Apotex Corp. Issues Voluntary Nationwide Recall of Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) due to the potential for Detection of an Amount of Unexpected Impurity,N-nitrosodimethylamine (NDMA) Impurity in the product

September 24, 2019

• Sandoz Recalls Generic Zantac in US in Wake of Sales Halt

September 23, 2019

• Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP

September 19, 2019

• All Unexpired Lots of Eye Drug Recalled

September 19, 2019

• Antihistamine Recalled

September 13, 2019

• KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility

September 10, 2019

• The Metrix Company of Dubuque, Iowa is Recalling Specific Lots of the Empty IV Flexible Containers (Bag) Marketed Under the Metrix Secure EVA Dual Chamber and Baxter ExactaMix Names, Due to the Potential for Leaking of the IV Bag at the Chamber Divider Rod

September 9, 2019

• Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL due to Microbial Contamination

September 6, 2019

• Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance

August 27, 2018

• FDA requests recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy, reminds patients and health care professionals to stop using due to potential risks

August 22, 2019

• Anticonvulsant Recalled

August 22, 2019

• Antiplatelet Agent Recalled

August 15, 2019

• Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

August 9, 2019

• Antibiotic Tablets Recalled

August 9, 2019

• Oral Contraceptive Recalled

August 8, 2019

• Ridge Properties LLC DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of PRE-TAT

August 1, 2019

• Chemotherapy Tablets Recalled

August 1, 2019

• Blood Pressure Pills Pulled

August 1, 2019

• Over 135,000 Containers of Fluid Injection Recalled

July 25, 2019

• Over 330,000 Bags of Heart Failure Treatment Recalled

July 23, 2019

• Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results

July 19, 2019

• Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

July 11, 2019

• Gamunex-C 10% Consumer Level Withdrawal

July 10, 2019

• Altaire Pharmaceuticals, Inc. Voluntary Recall of Multiple Ophthalmic Products Sold at CVS

July 5, 2019

• Parkinson Disease Drug Pulled

July 5, 2019

• Sedative Injection Recalled

July 5, 2019

• lSurgical Injection Recalled

July 3, 2018

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Walgreens

July 3, 2019

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products

July 3, 2019

• Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection

June 28, 2019

• Gamunex-C 10% Consumer Level Withdrawal

June 27, 2019

• Cetirizine Oral Solution Recalled

June 27, 2019

• Breast Cancer Drug Recalled

June 25, 2019

• Losartan Potassium and Losartan HCTZ Recall

June 20, 2019

• Heparin Sodium in Dextrose Recall

June 20, 2019

• Zyflo CR Recall

June 20, 2019

• Pecgen DMX Cough Suppressant Expectorant (Class I) Recall

May 29, 2019

• CVS Brand Meds Recalled

May 29, 2019

• Recall Active for Promacta

May 29, 2019

• Over 170,000 Bottles of Prescription Laxative Recalled

May 23, 2019

• Additional Recalls issued for Losartan Potassium Tablets

May 11, 2019

• Novartis Issues Voluntary Nationwide Recall of Promacta

May 9, 2019

• Four Firms Issue New Recalls for Losartan

May 9, 2019

• Diabetes Drug Recalled

May 9, 2019

• Class II Recall Active for Hydromorphone

May 9, 2019

• Recall Active for Bevacizumab

April 4, 2019

• FDA Recalls Fayosim Tablets

April 4, 2019

• Class II Recall Active for Combigan

March 30, 2019

• Hypertension Drug Recalled

March 30, 2019

• Antibiotic Eye Drops Recalled

March 4, 2019

• FDA Issues Safety Alert for JAK Inhibitor

March 4, 2019

• Apotex Corp Issues Voluntary Recall of Drospirenone and Ethinyl Estradiol Tablets

March 1, 2019

• Aurobindo Pharmaceuticals Limited Issues Valsartan Amlodipine Tablets Recall

February 28, 2019

• Camber Pharmaceuticals Limited Issues Losartan Potassium Recall

February 22, 2019

• Macleods Pharmaceuticals Limited Issues Losartan Potassium/HCT Recall

February 8, 2019

• Antibiotic Recalled

February 8, 2019

• Hypertension Drug Recalled

February 8, 2019

• Antihistamine Pulled

February 8, 2019

• Blood Pressure-Water Pill Recalled

February 4, 2019

• Medex Cardio Pulmonary recalls Sterile Saline and Sterile Water

February 3, 2019

• Blood Thinner Recalled

February 2, 2019

• Topical Steroid Recalled

February 2, 2019

• Cholesterol Drug Recalled

February 1, 2019

• Terrific Care LLC Medex Supply Recalls CoaguCheck XS Test Strips

January 18, 2019

• Surgical Muscle Relaxant Pulled in Class I Recall

January 18, 2019

• Oral Suspension Antibiotic Recalled

January 18, 2019

• Intravitreal Corticosteroid Implant Recalled

January 18, 2019

• Class I Recall of Antibiotic Injection

January 1, 2019

• New Opioid Prescription Safety Measures

December 7, 2018

• Acne Cream Recalled Over Impurities

December 7, 2018

• Antipsychotic Drug Recalled

December 7, 2018

• Anemia Injection Recalled

December 7, 2018

• FDA alerts health care professionals and patients not to use drug products intended to be sterile from Promise Pharmacy

December 5, 2018

• Infant Ibuprofen Recalled

December 4, 2018

• Mylan expands Voluntary Recall of Valsartan

December 4, 2018

• Blood Thinner Pulled

November 30, 2018

• Chewable Antacids Recalled

November 30, 2018

• Mylan to Recall All Batches of Blood Pressure Medicine Valsartan in US

November 8, 2018

• Nationwide Recall of Losartan

November 8, 2018

• Opioid Solution recalled

November 8, 2018

• Analgesic Solution Recalled

November 8, 2018

• Hypertension Drug Recalled

November 2, 2018

• Epi-Pen Alert

November 2, 2018

• Diuretic Recalled

November 2, 2018

• Antibiotic Injection Recalled

November 2, 2018

• Skin Solution Recalled

November 2, 2018

• Intravenous Antiviral Recalled

November 2, 2018

• Beta Blocker Pulled

October 12, 2018

• Class l Recall for Muscle Relaxant

October 12, 2018

• Steroid-Antifungal Cream Recalled

October 12, 2018

• Biopharmaceutical Recalled

October 12, 2018

• Antipsychotic Pulled

September 27, 2018

• Muscle Relaxant Pulled After Diabetes Drug Found.

September 27, 2018

• Over 15,000 Bottles of Anticonvulsant Recalled.

August 24, 2018

• Contaminant Prompts Recall of Ace Inhibitor

August 24, 2018

• Chemotherapy Drug Recalled

August 24, 2018

• Recall of Blood Pressure Drug Expands

August 23, 2018

• Updated additional lots added-Torrent Pharmaceuticals

August 10, 2018

• Antibiotic Tablets Recalled

August 10, 2018

• Antibiotic Vials Recalled

August 10, 2018

• NSAID Capsules Pulled

August 9, 2018

• Camber Pharmaceuticals-Valsartan Recall

August 9, 2018

• Levothyroxine and Liothyronine Recall

July 31, 2018

• AuroMedicas Piperacillin/Tazobactam Injection Recall

July 27, 2018

• Antibiotic Recall

July 27, 2018

• Multiple Pain Killers Pulled

July 27, 2018

• Blood Pressure Med Recalled

July 27, 2018

• Epinephrine Injection Recalled

July 27, 2018

• Diabetes Tablets Recalled

July 17, 2018

• Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

July 17, 2018

• Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

July 13, 2018

• Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)

May 31, 2018

• Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter

June 4, 2018

• Fluticasone Propionate Nasal Spray by Apotex Corp: Recall - Due to Potential for Small Glass Particless

February 16, 2018

• Two Injectable Drugs Recalled

February 16, 2018

• Class I Recall: Injectable Antibiotic

February 7, 2018

• COPD Inhaler Capsules Recalled

February 1, 2018

• Expansive Ibuprofen Recall

February 1, 2018

• Class II Statin Recall

February 1, 2018

• Cancer Drug Recalled

January 26, 2018

• Chemotherapy Drug Recalled

January 26, 2018

• Antiseizure Tablets Recalled

January 26, 2018

• Statin Recalled

January 19, 2018

• Dozens of Compounded Preparations Recalled

January 19, 2018

• Hypertension Drug Recalled

January 16, 2018

• Safety Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter - Anaphylaxis and Other Serious Hypersensitivity Reactions

January 12, 2018

• Safety Alert: Becton-Dickinson (BD) Syringes Used to Store Compounded or Repackaged Drugs: FDA Alert - Problematic Rubber Stoppers Replaced

January 12, 2018

• Prefilled Injections Shipped with Wrong Drug

January 12, 2018

• Class I Recall: Prescription Diarrhea Med

January 12, 2018

• Recall: Depression Drug

January 10, 2018

• Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling

January 5, 2018

• Compounded Injectable Drugs Recalled